PRODUCTS

  • PRODUCTS

Medical artificial intelligence software

AITRICS-VC

  • Approved by the Ministry of Food and Drug Safety (Manufacturing License No. 22-723)
  • Recognized as an Innovative Medical Device (No. 27)
  • Selected for eligibility in the conditional nHTA (new Health Technology Assessment) approval program

What is the Vital Sign Analysis Software AITRICS-VC? Product Introduction Video

AITRICS-VC is a software that uses EMR data from hospitalized patients aged 19 and older to predict the risk of major adverse events(mortality, unexpected ICU transfer, CPR), sepsis, and CPR in general wards, as well as the risk of acute deterioration (mortality) in the ICU.

To predict a patient's abnormal signs as accurately as possible, AITRICS-VC utilizes up to 19 different data points, including vital signs, blood test results, GCS, and the patient's age.

※ 19 data points

  • - 6 Vital Signs: Systolic blood pressure, Diastolic blood pressure, Pulserate, Respiration rate, Temperature, SpO2
  • - 11 Blood Test Results: Total bilirubin, Lactic acid, pH, Sodium, Potassium, Creatinine, Hematocrit, White blood cells(WBC), Bicarbonate(HCO3), Platelets, C반응성 단백질C-reactive protein(CRP)
  • - Glasgow Coma Scale(GCS)
  • - Age

Patients Admitted to
General Wards

GW(General Ward)

SEPS(SEPsis Score)

Provides a predictive score to identify patients at risk of developing sepsis in general wards within four hours

* The pivotal clinical trial, conducted on 3,668 inpatients, demonstrated a sepsis prediction accuracy (AUROC1)) of 0.869 in general wards.

MAES(Major Adverse Events Score)

Provides a predictive score to identify patients at risk of developing acute major adverse events in general wards within six hours

Acute major adverse events

  • Mortality
  • ICU transfer
  • Cardiac arrest

* The pivotal clinical trial conducted on 2,953 inpatients demonstrated a prediction accuracy (AUROC) of 0.961 for major adverse events (i.e. mortality, ICU transfer, cardiac arrest) in general wards.

Patients Admitted to ICUs

ICU(Intensive Care Unit)

MORtality Score

Provides a predictive score to identify patients at risk of developing acute deterioration in ICUs within six hours

* The pivotal clinical trial conducted on 754 inpatients demonstrated a prediction accuracy (AUROC) of 0.975 for mortality in the ICU.

1) AUROC : A performance metric to evaluate scoring schemes. An AUROC closer to 1 indicates better prediction performance.

AITRICS-VC

FEATURES

AITRICS-VC aids medical professionals in making medical judgments based on AI analytical results
to detect abnormalities in patients at an early stage, resulting in improved operational efficiency in hospitals.

※ Hover to see more details

Patient classification

Provides data for sorted patients by classifying them as
“Newly Admitted, Observation, Completed, Error, or DNR”.

Alarm

Provides the latest alarm history for sorted patients,
the alarm setoff time and the grounds for sorting.

AITRICS-VC predictive score

Provides the latest predictive score and the percentage change
from the previous predictive score.

Early Warning Score(Early Warning Score, EWS)

Provides the Modified Early Warning Score (MEWS) and
National Early Warning Score (NEWS) on a single screen.

Vital Sign

Provides up-to-date vital signs of patients sorted
by screening criteria.

HOW TO

STEP 01

Collection & use of
electronic medical
records (EMRs)

Allows users to monitor patients’
status on the PC screen by
connecting it to the
hospital's internal network.

STEP 02

AITRICS-VC's artificial intelligence model

Calculation of
predictive scores

Utilizes up to 19 different
data sources,
ranging from inpatients’
vital signs, blood test results,
and age to Glasgow Coma Scale.

STEP 03

Identifying patient
abnormalities early on

Enabling prompt responses by medical professionals

It identifies patient abnormalities
early
on with predictive scores
and enables prompt response
by medical professionals.

※ This product is a medical device. Please be sure to read the 'Precautions' and 'Instructions for Use' before use.